Connection

Chris Gale to Adrenergic beta-Antagonists

Back to Details
This is a "connection" page, showing publications Chris Gale has written about Adrenergic beta-Antagonists.
Chris Gale
Connection Strength
1.239
Adrenergic beta-Antagonists
  1. Registry-based randomised clinical trial: efficient evaluation of generic pharmacotherapies in the contemporary era. Heart. 2018 10; 104(19):1562-1567.
    View in: PubMed
    Score: 0.547
  2. ß-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction. J Am Coll Cardiol. 2017 Jun 06; 69(22):2710-2720.
    View in: PubMed
    Score: 0.515
  3. Effect of oral ß-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2019 01 01; 5(1):12-20.
    View in: PubMed
    Score: 0.144
  4. Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013. Cancer. 2018 03 15; 124(6):1269-1278.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.